UFP Industries will announce its third quarter 2026 financial results after the market closes on October 28, 2026. The company will hold a conference call on October 29 at 10:00 a.m. Eastern Time, hosted by its CEO and CFO, to discuss the results. Investors can access a live webcast and supporting materials on the UFP Industries Investor Relations website. A replay of the call will be available for at least 90 days, providing ample opportunity for investors to review the company's performance and outlook.
UFP Industries' upcoming third quarter financial results announcement is presented here with Industrials sector data from Pluang as context. Among 93 priced US Industrials stocks on Pluang, 65 rose and 27 fell today. Notably, FuelCell Energy Inc (FCEL) gained 11.62% to USD 20.17 with a typical hold time of 48 days and strong buy interest at 86%, contrasting with BWX Technologies (BWXT) at USD 146.80, up 8.46% but held for only 8 days. FTAI Aviation Ltd (FTAI) also rose 7.54% to USD 177.12, held typically for 22 days with exclusively buy orders. Data is as of Oct 07, 2026 00:02 WIB.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
